Best reviewers of Hypertension Research 2023

Kazuomi Kario

DOI: https://doi.org/10.1038/s41440-024-01626-6

2024-04-27

Hypertension Research

Abstract:Hypertension Research, Published online: 26 April 2024; doi:10.1038/s41440-024-01626-6 Best reviewers of Hypertension Research 2023

peripheral vascular disease

What problem does this paper attempt to address?

Winners for the 15th Hypertension Research Awards and outstanding papers in Hypertension Research

Kazuomi Kario

DOI: https://doi.org/10.1038/s41440-024-02014-w

2024-11-29

Hypertension Research

Abstract:Hypertension Research, Published online: 28 November 2024; doi:10.1038/s41440-024-02014-w Winners for the 15th Hypertension Research Awards and outstanding papers in Hypertension Research

peripheral vascular disease
Original article and review highlighted in this month of Hypertension Research

Satoshi Hoshide,Masaki Mogi,Kazuomi Kario

DOI: https://doi.org/10.1038/s41440-024-01646-2

2024-05-07

Hypertension Research

Abstract:Hypertension Research, Published online: 07 May 2024; doi:10.1038/s41440-024-01646-2 Original article and review highlighted in this month of Hypertension Research

peripheral vascular disease
Intriguing review and topics in this month of Hypertension Research

Satoshi Hoshide,Masaki Mogi,Kazuomi Kario

DOI: https://doi.org/10.1038/s41440-023-01532-3

2024-02-06

Hypertension Research

Abstract:Hypertension Research, Published online: 05 February 2024; doi:10.1038/s41440-023-01532-3 Intriguing review and topics in this month of Hypertension Research

peripheral vascular disease
The Editorial Structure 2024 of Hypertension Research for global initiatives

Kazuomi Kario,Satoshi Hoshide,Masaki Mogi

DOI: https://doi.org/10.1038/s41440-023-01548-9

2024-01-04

Hypertension Research

Abstract:Hypertension Research, Published online: 04 January 2024; doi:10.1038/s41440-023-01548-9 The Editorial Structure 2024 of Hypertension Research for global initiatives

peripheral vascular disease
Hypertension research 2024 update and perspectives: basic research

Kento Kitada

DOI: https://doi.org/10.1038/s41440-024-01878-2

2024-09-09

Hypertension Research

Abstract:This review article introduces some basic studies that were recently published in this journal, as a part of Hypertension Research 2024 Update and Perspectives. Including recent basic research trends in other scientific journals, we would like to summarize basic research on keywords such as hypertension and its associated organ damage, new treatments, and others. It is expected that the accumulation of basic studies will lead to breakthroughs in hypertension treatment in the future and lead to the definitive treatment of hypertension beyond blood pressure control with anti-hypertensive drugs.

peripheral vascular disease
Latest hypertension research to inform clinical practice in Asia

Kazuomi Kario,Masaki Mogi,Satoshi Hoshide

DOI: https://doi.org/10.1038/s41440-022-00874-8

2022-04-01

Hypertension Research

Abstract:Despite the challenges associated with the coronavirus pandemic, the last 2 years have been active periods for hypertension research and initiatives in Asia. There are new hypertension guidelines from the World Health Organization that can be interpreted and applied locally. This is also the case for data from the latest Blood Pressure Lowering Treatment Trialists' Collaboration meta-analysis, which showed that greater reductions in systolic blood pressure (BP) are associated with lower risks of cardiovascular events. The randomized controlled Strategy of Blood Pressure Intervention in the Elderly Hypertensive study and the Salt Substitute and Stroke Study provide local data to inform practice. Other initiatives to help reduce high salt intake in Asia are also underway. Both drug-resistant and nocturnal hypertension are appropriate areas of focus in Asia, and there are an increasing number of pharmacological and non-pharmacological treatment options for these conditions. Digital therapeutics to promote uptake and implementation of lifestyle interventions are showing promise, and other digital-based strategies such as telemedicine, wearable BP monitors to detect beat-by-beat BP and artificial intelligence will no doubt become integral parts of future strategies to reduce the burden of hypertension and hypertension-related disease. A number of initiatives from the Hypertension Cardiovascular Outcome Prevention and Evidence in Asia Network and Japanese Society of hypertension are underway, and there is good reason for optimism regarding the ongoing and future management of hypertension in Asia based on these and the active research activities in the region.

peripheral vascular disease
The need for a personalized "implementation hypertension" strategy to facilitate the implementation of the new European Society of Hypertension (2023), European Society of Cardiology (2024) and the upcoming Japanese Society of Hypertension (2025) hypertension guidelines in clinical practice

Kazuomi Kario,Satoshi Hoshide,Masaki Mogi

DOI: https://doi.org/10.1038/s41440-024-01927-w

2024-10-07

Hypertension Research

Abstract:Hypertension Research, Published online: 07 October 2024; doi:10.1038/s41440-024-01927-w The need for a personalized "implementation hypertension" strategy to facilitate the implementation of the new European Society of Hypertension (2023), European Society of Cardiology (2024) and the upcoming Japanese Society of Hypertension (2025) hypertension guidelines in clinical practice

peripheral vascular disease
Current topic of vascular function in hypertension in 2023–2024

Tatsuya Maruhashi,Yukihito Higashi

DOI: https://doi.org/10.1038/s41440-024-01885-3

2024-09-20

Hypertension Research

Abstract:Noninvasive tests of vascular function are useful for assessing the severity of atherosclerosis and risk of cardiovascular events, understanding the pathophysiology of cardiometabolic disorders, and investigating the effects of therapeutic interventions on cardiovascular morbidity and mortality, all of which can provide additional information for the management of patients with cardiovascular risk factors or a history of cardiovascular disease. In 2023–2024, many excellent articles on vascular function were published in Hypertension Research and other major cardiovascular and hypertension journals, and we summarize the emerging evidence on vascular function in this review. We hope that this review will be helpful for the management of patients with cardiovascular risk factors in clinical practice and for future basic and clinical research on vascular function.

peripheral vascular disease
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Satoshi Umemura,Hisatomi Arima,Shuji Arima,Kei Asayama,Yasuaki Dohi,Yoshitaka Hirooka,Takeshi Horio,Satoshi Hoshide,Shunya Ikeda,Toshihiko Ishimitsu,Masaaki Ito,Sadayoshi Ito,Yoshio Iwashima,Hisashi Kai,Kei Kamide,Yoshihiko Kanno,Naoki Kashihara,Yuhei Kawano,Toru Kikuchi,Kazuo Kitamura,Takanari Kitazono,Katsuhiko Kohara,Masataka Kudo,Hiroo Kumagai,Kiyoshi Matsumura,Hideo Matsuura,Katsuyuki Miura,Masashi Mukoyama,Satoko Nakamura,Takayoshi Ohkubo,Yusuke Ohya,Takafumi Okura,Hiromi Rakugi,Shigeyuki Saitoh,Hirotaka Shibata,Tatsuo Shimosawa,Hiromichi Suzuki,Shori Takahashi,Kouichi Tamura,Hirofumi Tomiyama,Takuya Tsuchihashi,Shinichiro Ueda,Yoshinari Uehara,Hidenori Urata,Nobuhito Hirawa

DOI: https://doi.org/10.1038/s41440-019-0284-9

2019-08-02

Hypertension Research

Abstract:<p>Hypertension Research, Published online: 02 August 2019; <a href="https://www.nature.com/articles/s41440-019-0284-9">doi:10.1038/s41440-019-0284-9</a></p>The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

peripheral vascular disease
Ambulatory blood pressure monitoring and left ventricular morphology

Takuro Kubozono

DOI: https://doi.org/10.1038/s41440-024-01993-0

2024-11-08

Hypertension Research

Abstract:Hypertension Research, Published online: 07 November 2024; doi:10.1038/s41440-024-01993-0 Ambulatory blood pressure monitoring and left ventricular morphology

peripheral vascular disease
Top Ten Breakthroughs in Clinical Hypertension Research in 2022

Qiaoxi Yang,Jun Cai

DOI: https://doi.org/10.15212/cvia.2023.0054

2023-01-01

Cardiovascular Innovations and Applications

Abstract:Hypertension is a major global public health concern whose disease burden affects an estimated 1.4 billion people worldwide and is associated with 10.8 million deaths annually. Despite substantial advances in medical care, the prevalence of hypertension has markedly increased, owing to population aging; poor treatment adherence; and increases in risk factors, such as excessive salt intake, and overweight and obesity. Consequently, the disability-adjusted life years have increased by 40%, primarily because of elevated risk of stroke, coronary atherosclerosis, heart failure, and kidney failure. Major outstanding problems associated with the treatment and management of hypertension include determining optimal blood pressure targets, developing innovative antihypertensive medications and devices, and implementing effective and feasible hypertension management strategies. To address these challenges, numerous clinical trials are currently underway. This article highlights the most influential ten clinical studies on hypertension in 2022. The rational use of antihypertensive medications is concluded to be important for effective hypertension management. Important considerations include medication types and dosing times; optimal blood pressure targets; the development of new drugs and therapeutic devices; specific community characteristics, such as village doctor-led care; and healthful diets.
The clinical significance of home and office blood pressure in diabetic nephropathy

Daisuke Suzuki,Satoshi Hoshide,Kazuomi Kario

DOI: https://doi.org/10.1038/s41440-023-01239-5

2023-03-04

Hypertension Research

Abstract:Hypertension Research, Published online: 03 March 2023; doi:10.1038/s41440-023-01239-5 The clinical significance of home and office blood pressure in diabetic nephropathy

peripheral vascular disease
Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration

Keisuke Shinohara

DOI: https://doi.org/10.1038/s41440-023-01176-3

2023-01-17

Hypertension Research

Abstract:The pathogenesis of hypertension is multifactorial and highly complex. Basic research plays critical roles in elucidating the complex pathogenesis of hypertension and developing its treatment. This review covers recent topics in basic research related to hypertension in the following six parts: brain/autonomic nervous system, kidney, vascular system, potential treatments, extracellular vesicles, and gut microbiota. The brain receives afferent nerve inputs from peripheral organs, including the heart, kidneys, and adipose tissue, and humoral inputs from circulating factors such as proinflammatory cytokines and leptin, which are involved in the regulation of central sympathetic outflow. In the kidneys, changes in Wnt/β-catenin signaling have been reported in several hypertensive models. New findings on the renin-angiotensin-aldosterone system in the kidneys have also been reported. Sirtuin 6, which participates in various cellular functions, including DNA repair, has been shown to have protective effects on the vascular system. Skin water conservation, mediated by skin vasoconstriction and the accumulation of osmolytes such as sodium, has been found to contribute to hypertension. Studies of rivaroxaban and sodium-glucose cotransporter-2 inhibitors as drug repositioning candidates have been performed. Extracellular vesicles have been shown to be involved in novel diagnostic approaches and treatments for hypertension as well as other diseases. In gut microbiota studies, interactions between microbiota and antihypertensive drugs and potential pathophysiology linking microbiota and COVID-19 have been reported. It can be seen that inter-organ communication has received particular attention from these recent research topics. To truly understand the pathogenesis of hypertension and to develop treatments for conquering hypertension, interresearcher communication and collaboration should be further facilitated.

peripheral vascular disease
Arterial hypertension-clinical trials update 2024

Mert Tokcan,Lucas Lauder,Felix Götzinger,Michael Böhm,Felix Mahfoud

DOI: https://doi.org/10.1038/s41440-024-01900-7

Abstract:Arterial hypertension remains the most important modifiable cardiovascular risk factor for morbidity and mortality worldwide. This review summarizes and discusses major clinical trials published in 2023 and early 2024 in hypertension research. These trials include new epidemiological data, studies investigating the impact of blood pressure cuff size on blood pressure measurements, benefits of salt substitutes, and novel antihypertensive treatment options, including pharmacotherapy and bariatric surgery in patients with obesity. This summary reviews the major clinical trials published in 2023 and early 2024. AHT arterial hypertension, BP blood pressure, HR hazard ratio, OBP office blood pressure, PRA plasma renin activity, SBP systolic blood pressure.
Taking action for controlling high blood pressure: challenges in the real world

Toshiki Maeda

DOI: https://doi.org/10.1038/s41440-024-01711-w

2024-05-21

Hypertension Research

Abstract:Hypertension Research, Published online: 20 May 2024; doi:10.1038/s41440-024-01711-w Taking action for controlling high blood pressure: challenges in the real world

peripheral vascular disease
2020 International Society of Hypertension global hypertension practice guidelines.

G. Stergiou,N. Poulter,B. Williams,A. Schutte,C. Borghi,Nadia A. Khan,D. Prabhakaran,A. Ramirez,T. Unger,R. Wainford,M. Schlaich,M. Tomaszewski,F. Charchar

DOI: https://doi.org/10.1097/HJH.0000000000002453

IF: 4.9

2020-06-01

Journal of Hypertension

Abstract:DOCUMENT REVIEWERS Hind Beheiry (Sudan), Irina Chazova (Russia), Albertino Damasceno (Mozambique), Anna Dominiczak (UK), Anastase Dzudie (Cameroon), Stephen Harrap (Australia), Hiroshi Itoh (Japan), Tazeen Jafar (Singapore), Marc Jaffe (USA), Patricio Jaramillo-Lopez (Colombia), Kazuomi Kario (Japan), Giuseppe Mancia (Italy), Ana Mocumbi (Mozambique), Sanjeevi N.Narasingan (India), Elijah Ogola (Kenya), Srinath Reddy (India), Ernesto Schiffrin (Canada), Ann Soenarta (Indonesia), Rhian Touyz (UK), Yudah Turana (Indonesia), Michael Weber (USA), Paul Whelton (USA), Xin Hua Zhang, (Australia), Yuqing Zhang (China).

Medicine
Extracting the essence of digital therapeutics for hypertension

Midori Yatabe

DOI: https://doi.org/10.1038/s41440-024-01968-1

2024-11-08

Hypertension Research

Abstract:Hypertension Research, Published online: 07 November 2024; doi:10.1038/s41440-024-01968-1 Extracting the essence of digital therapeutics for hypertension

peripheral vascular disease
Acknowledgement of Reviewers for 2023

DOI: https://doi.org/10.1177/01632787241246885

2024-05-26

Evaluation & the Health Professions

Abstract:Evaluation &the Health Professions, Volume 47, Issue 2, Page 230-231, June 2024.

health care sciences & services,health policy & services
Angiotensin receptor–neprilysin inhibitors for hypertension—hemodynamic effects and relevance to hypertensive heart disease

Kazuomi Kario,Bryan Williams

DOI: https://doi.org/10.1038/s41440-022-00923-2

2022-05-03

Hypertension Research

Abstract:Hypertension Research, Published online: 02 May 2022; doi:10.1038/s41440-022-00923-2 Potential mechanisms contributing to the effects of angiotensin receptor–neprilysin inhibitors (ARNIs) on 24-h blood pressure and hypertensive heart disease. CV, cardiovascular; LV, left ventricular.

peripheral vascular disease
New anthropometric measurement alternatives to BMI and hypertension

Teruhide Koyama

DOI: https://doi.org/10.1038/s41440-023-01173-6

2023-01-14

Hypertension Research

Abstract:Hypertension Research, Published online: 13 January 2023; doi:10.1038/s41440-023-01173-6 New anthropometric measurement alternatives to BMI and hypertension

peripheral vascular disease

Best reviewers of Hypertension Research 2023

Winners for the 15th Hypertension Research Awards and outstanding papers in Hypertension Research

Original article and review highlighted in this month of Hypertension Research

Intriguing review and topics in this month of Hypertension Research

The Editorial Structure 2024 of Hypertension Research for global initiatives

Hypertension research 2024 update and perspectives: basic research

Latest hypertension research to inform clinical practice in Asia

The need for a personalized "implementation hypertension" strategy to facilitate the implementation of the new European Society of Hypertension (2023), European Society of Cardiology (2024) and the upcoming Japanese Society of Hypertension (2025) hypertension guidelines in clinical practice

Current topic of vascular function in hypertension in 2023–2024

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Ambulatory blood pressure monitoring and left ventricular morphology

Top Ten Breakthroughs in Clinical Hypertension Research in 2022

The clinical significance of home and office blood pressure in diabetic nephropathy

Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration

Arterial hypertension-clinical trials update 2024

Taking action for controlling high blood pressure: challenges in the real world

2020 International Society of Hypertension global hypertension practice guidelines.

Extracting the essence of digital therapeutics for hypertension

Acknowledgement of Reviewers for 2023

Angiotensin receptor–neprilysin inhibitors for hypertension—hemodynamic effects and relevance to hypertensive heart disease

New anthropometric measurement alternatives to BMI and hypertension